Good to see an expected date for first patient enrolment.
18month timeframe is a long runway though, however the sales trajectory of TR PRO+ and the added launch in 2025 with the additional indications could prove to be a solid revenue generator to mitigate the need for additional capital. Phase 3 trials are expensive so the risk now is funding for Phase 3 activities. Ramp of of sales reps and territory managers will eat more of the cash on hand, how quickly can they scale TR PRO+ is the million dollar question.
For now I have taken a profit and exited my position after holding for 12months, will look for re-entry closer to Phase3 read out dates.
Good luck guys.
Ann: Company Update - Presentation, page-2
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.020(4.71%) |
Mkt cap ! $24.48M | |||
| Open | High | Low | Value | Volume |
| 43.0¢ | 43.0¢ | 40.5¢ | $18.53K | 44.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27500 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 3907 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| TRP (ASX) Chart |